Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-25-047301
Filing Date
2025-03-05
Accepted
2025-03-05 16:50:18
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC TO-C d795772dsctoc.htm SC TO-C 29627
2 EX-99.1 d795772dex991.htm EX-99.1 20271
3 EX-99.2 d795772dex992.htm EX-99.2 13965
4 GRAPHIC g795772dsp2.jpg GRAPHIC 87939
5 GRAPHIC g795772dsp2a.jpg GRAPHIC 84646
6 GRAPHIC g795772dsp_1.jpg GRAPHIC 90970
7 GRAPHIC g795772g99n09.jpg GRAPHIC 141949
  Complete submission text file 0001193125-25-047301.txt   616369
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Subject) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87690 | Film No.: 25712045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filed by) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)